Business Daily from THE HINDU group of publications
Friday, Aug 08, 2008
ePaper | Mobile/PDA Version | Audio

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Home Page - Alternative Medicines
Corporate - Mergers & Acquisitions
Zandu-Emami row: HC asks CLB to pass orders in 15 days

P.T. Jyothi Datta
Jayanta Mallick

Mumbai/Kolkata, Aug. 7 The corporate tussle between ayurveda companies Zandu Pharmaceutical and Emami Ltd seems to have shifted to the Company Law Board.

The Bombay High Court on Thursday asked the CLB to pass its order in 15 days on the dispute between the two companies, legal counsel for one of the parties told Business Line.

Consequently, Zandu’s Annual General Meeting scheduled to be held this Saturday (August 9) now stands adjourned till the CLB passes its order, the source said.

Zandu had approached the Bombay High Court, asking for the CLB to look into the issue. Zandu alleged there had been a breach of the takeover code and non-compliance with MRTP laws.

The Mumbai-based Parikh family was unhappy after the Vaidyas (Zandu’s co-promoter family) sold their 24 per cent stake to Kolkata-based Emami.

Emami too is said to have petitioned Zandu’s promoters on not having received the agenda of the scheduled AGM.

Responding to today’s development, Mr Harsh Agarwal, Emami’s Executive Director, told Business Line: “It would be inappropriate to comment on the subject which is sub judice. But, we are very happy because chances of assertion of corporate democracy have brightened”.

In May, Emami announced that it had bought the Vaidyas’ stake in Zandu through a share purchase agreement, taking Emami’s total stake in Zandu up to 27.5 per cent.

Zandu’s promoter family holds over 20 per cent stake as on June 30. To stave-off Emami’s attempts to get a foot-hold in its company it had approached market-regulator SEBI and later, the CLB. However, the CLB reportedly advised Zandu’s promoters to take it up with SEBI.

Meanwhile, SEBI is yet to approve Emami’s open offer for 20 per cent stake in Zandu, slated to have opened on July 24.

Zandu’s shares were up around 5 per cent, at Rs 18,109, while Emami stock was a little over one per cent at Rs 242, on the BSE. But traded quantity in both the counters was very small.

Related Stories:
Emami may not have it easy on Zandu Pharma
Emami comes out with open offer for Zandu
Emami buys out Vaidyas in Zandu Pharma
Emami picks up more in Zandu Pharma
Emami’s Zandu acquisition

More Stories on : Alternative Medicines | Mergers & Acquisitions | Courts/Legal Issues | Regulatory Bodies & Rulings

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Hiring

Stories in this Section
Revived monsoon trims rain deficit to 1%


Dividend yield hopes buoy Indiabulls Securities
Emerging markets to boost mobile sales: Gartner
Inflation breaches 12% mark
MahaTransco to seek Govt approval for Rs 1,500-cr IPO
Day Trading Guide
NTC proposal to set up 7 new mills gets GoM panel nod
Dish TV India (Rs 37.55): Buy
Mamata open to talks on Tatas’ car plant issue
Q1 profits of auto parts makers take a beating
Two-wheeler cos increase prices
‘Attrition at Satyam among lowest in industry’
More banks hike lending rates
Added weightage for cos offering maximum piped gas connections
Govt may go ahead with BSNL IPO plan despite union protest
Zandu-Emami row: HC asks CLB to pass orders in 15 days


Life



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line